Résumé
No abstract available.
Sujets)
Femelle , Humains , Mâle , Maladie coronarienne/diagnostic , Stéatose hépatique alcoolique/diagnostic , Stéatose hépatique non alcoolique/diagnosticRésumé
No abstract available.
Sujets)
Humains , Antiviraux/usage thérapeutique , Ascites/diagnostic , Cholagogues et cholérétiques/usage thérapeutique , Stéatose hépatique/diagnostic , Stéatose hépatique alcoolique/diagnostic , Hémorragie/prévention et contrôle , Encéphalopathie hépatique/diagnostic , Hépatite B chronique/diagnostic , Hépatite C chronique/diagnostic , Cirrhose du foie/diagnostic , Cirrhose biliaire/traitement médicamenteux , Vasodilatateurs/usage thérapeutiqueRésumé
Sialadenosis is a unique form of non-inflammatory, non-neoplastic bilateral salivary gland disorder characterized by recurrent painless swelling which usually occurs in parotid glands. Alcoholism is one of the main causes of sialadenosis along with diabetes, bulimia, and other idiopathic causes. The prognosis is verified according to the degree of liver function. We present a case of a 46 year-old man who had alcoholic fatty liver disease diagnosed as alcoholic sialadenosis based on clinical points of recurrent bilateral parotid swelling after heavy alcohol drinking, computed tomography, and fine-needle aspiration biopsy. After stopping alcohol drinking and treated with conservative treatment, he got improved without specific sequela.
Sujets)
Adulte , Humains , Mâle , Consommation d'alcool , Stéatose hépatique alcoolique/diagnostic , Glande parotide/imagerie diagnostique , Tomographie par émission de positons , Sialadénite/diagnostic , TomodensitométrieRésumé
INTRODUCTION: Insulin resistance (IR) is common in patients with nonalcoholic fatty liver disease (NAFLD). We compared the performance of insulin tolerance test and the homeostasis model assessment (HOMA) for measuring IR in such patients. METHODS: In a prospective study, IR was determined using both insulin tolerance test and HOMA in 22 patients with NAFLD. Rate constant for insulin tolerance test (KITT) was calculated using the formula KITT (%/min) = 0.693/t(1/2), where t(1/2) was calculated from the slope of plasma glucose concentration during 3-15 minutes after administration of intravenous insulin. IR was assessed using HOMA as the product of fasting insulin (microU/L) and fasting plasma glucose (mmol/L) levels divided by 22.5. RESULTS: All the 22 patients had IR. Results of KITT and HOMA-IR for determining IR showed a fair correlation (r = 0.55; p = 0.03). CONCLUSIONS: Insulin tolerance test may be a useful method for assessing IR in patients with NAFLD.